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Drug-induced hypersensitivity syndrome (DIHS), also
known as drug reactions with eosinophila and systemic
symptoms, has unique clinical features including fever,
generalized rash, lymphadenopathy and extracutaneous
organ involvements. During the disease course, human
herpesvirus (HHV)-6 reactivation is frequently (60%<)
observed in association with unfavorable outcomes. We
recently noticed a transient increase of circulating
monocyte-sized cells that showed higher side scatter
counts in flowcytometer analysis before HHV-6 reactiva-
tions. These cells were CD14lowCD16+, like a minor
(<10%) monocyte subset that differentiates into ‘resident’
dendritic cells/macrophages, but were CD4- CD11a-
CD11b+ CD13int CD34- CD41ab- CD66b- CD117-
CD163- and contained rich organelles histologically,
suggesting mono-myeloid precursors, not bona fide
monocytes. We also found HHV-6 genome and antigens
in them. Since mono-myeloid cells in the bone marrow
are reportedly reservoirs of HHV-6, the mono-myeloid
precursors that emerged transiently in circulation in
DIHS patients might emigrate from the bone marrow,
and are suggested to play a special role of the virus
reactivation. Our observations will provide a scenario
that circulating mono-myeloid precursors bridge
between drug allergy and viral infection, which remains
poorly understood, in DIHS.
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